Carmustine 100mg
| Product Overview | |
| Generic Name | Carmustine 100mg |
| Brand Name(s) | BiCNU |
| Form | Vial for infusion w 3mL Diluent |
| Strength | 100 mg |
| Therapeutic Class | Nitrosourea alkylating antineoplastic |
| ATC Code | L01AD01 |
| Manufacturing & Regulatory | |
| Manufacturer | Bristol-Myers Squibb |
| Country | Mexico |
| GMP Compliance | WHO-GMP |
| DMF/CEP | Type II |
| COFEPRIS | 010.000.1758.00 |
| Free Sale Certificate | Yes, available as COPP/CPP |
| Logistics & Export | |
| MOQ | 10 units |
| Shelf Life | 24 months |
| Storage | 2–8 °C |
| Incoterms | Ex-Works Mexico |
| Lead Time | 7 to 10 Days |
| Documentation | |
| Certificate of Analysis (COA) | Yes—lot-specific Certificate of Analysis |
| CTD Summary | CTD from originator; generic use abbreviated formats |
Description
Carmustine is an antineoplastic chemotherapy agent from the nitrosourea / alkylating agent class. It works by damaging cancer-cell DNA, which interferes with replication and leads to tumor-cell death. Brain Tumors, Gliomas, multiple-myeloma, hodgkin lymphoma & non-hodgkin lymphoma
